Detailed Information

Cited 26 time in webofscience Cited 26 time in scopus
Metadata Downloads

Clinical whole exome sequencing in early onset diabetes patients

Authors
Kwak, Soo HeonJung, Chan-hyeonAhn, Chang HoPark, JungsunChae, JeesooJung, Hye SeungCho, Young MinLee, Dae HoKim, Jong-IlPark, Kyong Soo
Issue Date
Dec-2016
Publisher
ELSEVIER IRELAND LTD
Keywords
Genetic diagnosis; Maturity-onset diabetes of the young; Monogenic diabetes; Type 2 diabetes; Whole exome sequencing
Citation
DIABETES RESEARCH AND CLINICAL PRACTICE, v.122, pp.71 - 77
Journal Title
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume
122
Start Page
71
End Page
77
URI
https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7617
DOI
10.1016/j.diabres.2016.10.005
ISSN
0168-8227
Abstract
Aims: There could be an overlap of monogenic diabetes and early onset type 2 diabetes in those who are diagnosed before age of 30 years. Genetic diagnosis in these patients might improve the quality of care. A limited number of studies have used whole exome sequencing (WES) in Asian patients with early onset diabetes, and the clinical utility of WES is largely unknown. Methods: We performed whole exome capture and massive parallel sequencing in 28 patients with early onset diabetes. Those who had a strong family history of diabetes were preferentially enrolled. Rare and non-silent variants in 29 genes known to cause monogenic diabetes, including 12 maturity-onset diabetes of the young (MODY) genes, were investigated for pathogenicity. Results: The average depth of on-target WES reads was 97 X. A total of four pathogenic or likely pathogenic rare missense variants (p.Leu319Pro in HNF4A, p.His103Tyr and p.Arg74Gln in ABCC8, and p.Leu139Val in HNF1A) in MODY genes were identified in three patients. Although four rare non-silent variants in MODY genes (p.Arg183Cys in PAX4, p.Val139Ile and p.Pro740fs in CEL, and p.Val147Ile in HNF4A) and two rare non-silent variants in monogenic diabetes genes (p.Glu169Lys in WFS1, and p.Pro407Gln in GATA4) were identified, their pathogenicity was uncertain or likely benign. Conclusions: WES could be an initial option for genetic testing in patients with early onset diabetes. However, sufficient and universal coverage of genes of interest is required. In addition, it could be difficult to interpret variant pathogenicity, and these cases might require further validation. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
의과대학 > 의학과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Lee, Dae Ho photo

Lee, Dae Ho
College of Medicine (Department of Medicine)
Read more

Altmetrics

Total Views & Downloads

BROWSE